Women's Focus II 2005 Feature Releases.

SAN FRANCISCO -- The following release focuses on the topic Women's Focus II:

ALL TIME-OFFS ARE IN EASTERN TIME

WHITE PLAINS, N.Y.--A Clean Bill of Health Helps Build a Healthy Relationship (06/28/2005 - 12:00 PM, SOURCE: Vagisil Women's Health Center)

AVAILABLE EXPERTS

The following knowledgeable industry leaders and scholars from Business Wire's ExpertSource database are available to discuss topics relating to Women's Focus II:

--Dr. Joyce O'Shaughnessy is currently a breast cancer researcher and practitioner at Texas Oncology, P.A. in Dallas and is Associate Director for clinical research for US Oncology. She is also Director, Chemoprevention Research and Co-Director, Breast Cancer Research for US Oncology. Dr. O'Shaughnessy's major area of research interest is the development of breast cancer, and she is involved in several ongoing chemoprevention studies. She graduated cum laude from Yale University Medical School in 1982. Dr. O'Shaughnessy did her internship and residence in internal medicine at Massachusetts General Hospital, followed by her fellowship in medical oncology at the National Cancer Institute (NCI). She served as special assistant to the NCI director from 1988 to 1990 and coordinated the development of new cancer drug approval guidelines for the NCI and Food and Drug Administration. Dr. O'Shaughnessy then served as a Senior Investigator in the Medical Breast Cancer Section of the NCI from 1990 through 1995. In this role, she conducted many breast cancer treatment clinical trials, including evaluation of high-dose chemotherapies and hematopoietic growth factors, new cytotoxic drug combinations, novel hormonal treatments, monoclonal antibody and gene therapies for breast cancer. Dr. O'Shaughnessy also has served as principal investigator on several tissue-based breast cancer prevention clinical trials involving the administration of fenretinide, tamoxifen, and other SERMs to women at high risk for the development of breast cancer. Dr. O'Shaughnessy has been published and spoken widely on new prevention and treatment strategies for breast cancer. 214-370-1000, [e-mail]

--Joan Shaver, PhD, is a professor and dean of the College of Nursing at the University of Chicago. Her expertise includes the effects of menstruation, menopause and other female physiological characteristics on getting a good night's sleep. Dr. Shaver also studies fibromyalgia, a disease most common in women. 612-375-8570, [e-mail]

--Andrea Teichman is chair of the Hill & Barlow's Corporate Department. She represents a wide variety of business ventures, from high-tech and start-up companies, to public companies and VC funds in matters including PE financings, public offerings, M&As and sales of businesses. Ms. Teichman is also on the advisory board of The Commonwealth Institute, which promotes and mentors women business owners. She is also a member of the advisory committee for Springboard, a business plan competition and VC presentation for women entrepreneurs principally in technology and biotechnology fields. Ms. Teichman has been practicing law since 1984 and joined Hill & Barlow in 1991, where she has been a member since 1994. 617-428-3540, [e-mail]

Registered journalists can submit queries to the ExpertSource staff and/or search for more experts in this and various other topics by going to www.businesswire.com and logging in with your email address and PressPass password. If you are not registered, you may do so at www.businesswire.com. For more information or assistance with ExpertSource, please contact Stacey Seigler, ExpertSource Coordinator/Business Wire at 312/223-1037, [e-mail] .

The following are upcoming Features Package release dates: July 5- Back to School I July 14 - Fitness & Health II July 19 - Pets July 28 - Men's Focus II

Questions? Contact Business Wire's Media Relations team at [e-mail]